SCHEMBL24368570

SCHEMBL24368570

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc(-c5cc6c7ccccc7c7ccccc7c6s5)cc4)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.44
CYP1B1 Q16678 3/20 0.44
RAB9A P51151 7/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 3/20 0.40
APP P05067 1/20 0.40
MAPT P10636 1/20 0.40
PTP4A3 O75365 1/20 0.39
PTP4A2 Q12974 1/20 0.39
PTP4A1 Q93096 1/20 0.39
CYP1A2 P05177 2/20 0.38
ADORA2A P29274 2/20 0.37
ALDH1A1 P00352 5/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 2/20 0.36
NFKB1 P19838 1/20 0.36
CASP3 P42574 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24369566 1.00 CYP1A1 (0.44) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368534 1.00 CYP1A1 (0.44) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368540 1.00 CYP1A1 (0.44) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368533 1.00 CYP1A1 (0.44) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24369567 0.95 CYP1A1 (0.41) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368571 0.90 CYP1A1 (0.47) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368568 0.90 CYP1A1 (0.47) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL30704929 0.88 CYP1A1 (0.53) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1
SCHEMBL24368569 0.87 CYP1A1 (0.43) CYP1A1CYP1B1SMN1; SMN2APPCYP1A2
SCHEMBL2233095 0.86 APP (0.47) CYP1A1CYP1B1RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127277-A1 ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127277-A1 ORGANIC COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME CAPG, CAPZA1, OCIAD1 CYP1A1 702/4885CYP1B1 1033/4885RAB9A 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.